Quantessence Capital’s Synovus SNV Stock Holding History

Quantessence Capital’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,200	Closed	-$1.18M	–	406
2025 Q1	$1.18M	Buy	+25,200	New	+$1.3M	0.29%	77

Other funds holding SNV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NRCM

North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Quantessence Capital's SNV Position: Q2 2025 in Review

Quantessence Capital sold out of Synovus (SNV) in Q2 2025, closing a stake of 25,200 shares — an estimated $1.18M sold.

Quantessence Capital first reported a position in SNV in Q1 2025 and held it in 1 quarter. The position peaked at $1.18M in Q1 2025. 475 funds tracked by Wall St. Rank hold SNV as of Q2 2025.

Quantessence Capital reported no remaining Synovus position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 25,200 Synovus shares in Q2 2025, an estimated $1.18M.
Quantessence Capital first reported a position in Synovus in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Synovus position peaked at $1.18M in Q1 2025.
475 funds tracked by Wall St. Rank held Synovus as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.